Full Year 2021 Futura Medical PLC Earnings Call Transcript
Good morning, everybody, and welcome to the Futura Medical webcast for our preliminary results for the year ending the 31st of December 2021. I am James Barder, the CEO of the company; and I'm ably joined today by Angela Hildreth, who's the Finance Director and COO; and by Ken James, who is the Executive Head of R&D. First of all, obviously, we have our usual disclaimer, which I'm not going to go through word for word. I'll let you read at your leisure in due course.
Without further ado, let's move to Slide 4. A brief corporate overview. Futura is listed, obviously, our name, and we describe ourselves as a virtual organization with 13 staff and low overheads. We have a number of external consultants, around about 30, and we really have a significant outsourced infrastructure. Our key expertise or asset is applying skin science to deliver novel therapeutic treatments, topically applied, and we have a good track record of developing clinically proven innovation using existing Pharmaceutical compounds or novel applications. I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
